account_balance
Investment manager · 13F filer · SEC CIK 1692590
Vitruvian Partners LLP
Reported value$201Mas of Jun 30, 2026
Positions8 1 new, 0 sold out
Top 10 weight100.0%Marqeta Inc alone is 55%
FiledAug 1041 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
This fund reports 8 stocks.
Marqeta Inc
55.4%
HNGEHinge Health Inc
20.9%Trimmed −59%
XMTRXometry Inc
8.7%Trimmed −6%
CARGCargurus Inc
5.9%Trimmed −26%
GLBEGlobal E Online Ltd
3.6%
MXCTMaxcyte Inc
3.1%
WSE1.7%RXSTBox size is the share of the fund. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed